BRCA2 Antikörper
Kurzübersicht für BRCA2 Antikörper (ABIN2716687)
Target
Alle BRCA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- The fragment used for D immunization was expressed in E.coli and the purified protein fragment was used for affinity purification of the antibody.
-
Isotyp
- IgG
-
-
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 21-130) antibody
BRCA2 Reaktivität: Human WB, ELISA, IHC (p), IHC (fro), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) antibodyBRCA2 Reaktivität: Human, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2990-3232) antibodyBRCA2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 1-300) antibodyBRCA2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 3319-3418) antibodyBRCA2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3D12 unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2913-3151) antibodyBRCA2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2308-2537) antibodyBRCA2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2737-2874) antibodyBRCA2 Reaktivität: Zebrafisch (Danio rerio) WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (pSer3291) antibodyBRCA2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 251-495) antibodyBRCA2 Reaktivität: Human WB Wirt: Maus Monoclonal 1643CT739-91-87 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Andere Bezeichnung
- Brca2,fancd1
-
Pathways
- DNA Reparatur, M Phase, Maintenance of Protein Location
Target
-
